The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 10, 2026 | Robinson James A. Jr. | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Robinson James A. Jr. | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Lee June | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Lee June | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Katkin Keith | Director | Option exercise(M) | 9K | — | $0 |
| Jan 10, 2026 | Katkin Keith | Director | Option exercise(M) | 9K | — | $0 |
| Jan 10, 2026 | Kirk Allan | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Kirk Allan | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Hillson Jan | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | Hillson Jan | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | McBride John S. | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2026 | McBride John S. | Director | Option exercise(M) | 3K | — | $0 |
| Jan 10, 2025 | Kirk Allan | Director | Grant(A) | 3K | — | $0 |
| Jan 10, 2025 | Kirk Allan | Director | Grant(A) | 31K | — | $0 |
| Jan 10, 2025 | Lee June | Director | Grant(A) | 31K | — | $0 |
| Jan 10, 2025 | Lee June | Director | Grant(A) | 3K | — | $0 |
| Jan 10, 2025 | Perrin Steven | President, Director | Grant(A) | 243K | — | $0 |
| Jan 10, 2025 | Perrin Steven | President, Director | Grant(A) | 27K | — | $0 |
| Jan 10, 2025 | Little Paul Sean | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Jan 10, 2025 | Little Paul Sean | Chief Financial Officer | Grant(A) | 175K | — | $0 |
| Jan 10, 2025 | Robinson James A. Jr. | Director | Grant(A) | 3K | — | $0 |
| Jan 10, 2025 | Robinson James A. Jr. | Director | Grant(A) | 31K | — | $0 |
| Jan 10, 2025 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 151K | — | $0 |
| Jan 10, 2025 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 65K | — | $0 |
| Jan 10, 2025 | Katkin Keith | Director | Grant(A) | 9K | — | $0 |
| Jan 10, 2025 | Katkin Keith | Director | Grant(A) | 77K | — | $0 |
| Jan 10, 2025 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 67K | — | $0 |
| Jan 10, 2025 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 600K | — | $0 |
| Jan 10, 2025 | McBride John S. | Director | Grant(A) | 3K | — | $0 |
| Jan 10, 2025 | McBride John S. | Director | Grant(A) | 31K | — | $0 |
| Jan 10, 2025 | Hillson Jan | Director | Grant(A) | 3K | — | $0 |
| Jan 10, 2025 | Hillson Jan | Director | Grant(A) | 31K | — | $0 |
| Nov 21, 2024 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 1.0M | — | $0 |
| Nov 21, 2024 | Perrin Steven | President, Director | Grant(A) | 840K | — | $0 |
| Nov 21, 2024 | Little Paul Sean | Chief Financial Officer | Grant(A) | 525K | — | $0 |
| Nov 21, 2024 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 474K | — | $0 |
| Oct 29, 2024 | Biotechnology Value Fund II LP | Insider | Buy(P) | 2.2M | $3.65 | $8.1M |
| Oct 29, 2024 | Biotechnology Value Fund II LP | Insider | Buy(P) | 2.1M | $3.65 | $7.7M |
| Oct 29, 2024 | Biotechnology Value Fund II LP | Insider | Buy(P) | 440K | $3.65 | $1.6M |
| Jun 13, 2024 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 242K | — | $0 |
| Jun 13, 2024 | Perrin Steven | President, Director | Grant(A) | 428K | — | $0 |
| Jun 13, 2024 | Little Paul Sean | Chief Financial Officer | Grant(A) | 267K | — | $0 |
| Jun 13, 2024 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 517K | — | $0 |
| May 9, 2024 | BVF Inc | 10% Owner | Buy(P) | 1.0M | — | — |
| May 9, 2024 | BVF Inc | 10% Owner | Buy(P) | 821K | — | — |
| May 9, 2024 | BVF Inc | 10% Owner | Buy(P) | 75K | — | — |
| May 9, 2024 | BVF Inc | 10% Owner | Buy(P) | 232K | — | — |
| May 9, 2024 | BVF Inc | 10% Owner | Buy(P) | 3.2M | — | — |
| May 9, 2024 | BVF Inc | 10% Owner | Buy(P) | 2.5M | — | — |
| Oct 2, 2023 | Kirk Allan | Director | Grant(A) | 150K | $1.55 | $233K |
| Oct 2, 2023 | Robinson James A. Jr. | Director | Grant(A) | 150K | $1.55 | $233K |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 837K | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 86K | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 1.1M | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 252K | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 2.4M | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 1.6M | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 2.0M | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 166K | — | — |
| May 5, 2023 | Biotechnology Value Trading Fund OS LP | Insider | Buy(P) | 3.1M | — | — |
| May 1, 2023 | Hillson Jan | Director | Grant(A) | 150K | — | $0 |
| May 1, 2023 | Lee June | Director | Grant(A) | 150K | — | $0 |
| May 1, 2023 | Lyons Gary A | Director | Grant(A) | 150K | — | $0 |
| May 1, 2023 | McBride John S. | Director | Grant(A) | 150K | — | $0 |
| May 1, 2023 | Katkin Keith | Director | Grant(A) | 752K | — | $0 |
| May 1, 2023 | Little Paul Sean | Chief Financial Officer | Grant(A) | 198K | — | $0 |
| May 1, 2023 | Ogier Walter C | Director | Grant(A) | 150K | — | $0 |
| May 1, 2023 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 383K | — | $0 |
| May 1, 2023 | Perrin Steven | President, Director | Grant(A) | 317K | — | $0 |
| May 1, 2023 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 179K | — | $0 |
| Feb 1, 2023 | Little Paul Sean | Chief Financial Officer | Grant(A) | 155K | — | $0 |
| Feb 1, 2023 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 155K | — | $0 |
| Feb 1, 2023 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 300K | — | $0 |
| Feb 1, 2023 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 154K | — | $0 |
| Feb 1, 2023 | Hillson Jan | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2023 | Katkin Keith | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2023 | Lee June | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2023 | Lyons Gary A | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2023 | McBride John S. | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2023 | Ogier Walter C | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2023 | Perrin Steven | President, Director | Grant(A) | 155K | — | $0 |
| Nov 23, 2022 | Perrin Steven | President, Director | Buy(P) | 1K | $2.60 | $3K |
| Feb 1, 2022 | Little Paul Sean | Chief Financial Officer | Grant(A) | 155K | — | $0 |
| Feb 1, 2022 | Hillson Jan | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2022 | Katkin Keith | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2022 | Lee June | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2022 | Lyons Gary A | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2022 | McBride John S. | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2022 | Ogier Walter C | Director | Grant(A) | 20K | — | $0 |
| Feb 1, 2022 | Perrin Steven | President, Director | Grant(A) | 155K | — | $0 |
| Feb 1, 2022 | Smith Bryan E. | General Counsel, Corporate Sec | Grant(A) | 120K | — | $0 |
| Feb 1, 2022 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 108K | — | $0 |
| Dec 20, 2021 | Gros David-Alexandre C | Chief Executive Officer, Director | Buy(P) | 2K | $4.48 | $9K |
| Aug 17, 2021 | Gros David-Alexandre C | Chief Executive Officer, Director | Buy(P) | 4K | $6.21 | $25K |
| Jun 11, 2021 | Little Paul Sean | CHIEF FINANCIAL OFFICER | Buy(P) | 10K | $8.87 | $89K |
| Jun 9, 2021 | Gros David-Alexandre C | Chief Executive Officer, Director | Buy(P) | 3K | $8.01 | $24K |
| May 3, 2021 | Smith Bryan E. | See Remarks | Grant(A) | 159K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).